BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7093094)

  • 1. Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.
    Opie LH; White D; Lee J; Lubbe WF
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):115S-122S. PubMed ID: 7093094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
    Besterman EM; Spencer M
    Br J Clin Pharmacol; 1979; 8(Suppl 2):205S-209S. PubMed ID: 526402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Labetalol in hypertensive patients with angina pectoris: beneficial effect of combined alpha- and beta-adrenoreceptor blockade.
    Lubbe WF; White DA
    Clin Sci Mol Med Suppl; 1978 Dec; 4():283s-286s. PubMed ID: 32006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
    Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
    Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
    [No Abstract]   [Full Text] [Related]  

  • 5. Beneficial effect of labetalol in hypertensive patients with angina pectoris.
    Lubbe WF; White DA
    S Afr Med J; 1983 Jan; 63(3):67-71. PubMed ID: 6849167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience.
    Halprin S; Frishman W; Kirschner M; Strom J
    Am Heart J; 1980 Mar; 99(3):388-96. PubMed ID: 7355700
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris.
    Jee LD; Opie LH
    Am J Cardiol; 1985 Sep; 56(8):551-4. PubMed ID: 3929584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of combined alpha- and beta-adrenoceptor blockade in angina pectoris.
    Mulac KD
    Postgrad Med J; 1983; 59 Suppl 3():33-4. PubMed ID: 6647207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Labetalol in the treatment of stable exertional angina pectoris: a comparison with nifedipine.
    Crake T; Mulcahy D; Wright C; Fox K
    Eur Heart J; 1988 Nov; 9(11):1200-5. PubMed ID: 3069466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Sep; 2(3):369-76. PubMed ID: 3154919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined alpha and beta adrenoceptor blockade in patients with angina pectoris. A double blind study comparing labetalol with placebo.
    Quyyumi AA; Wright C; Mockus L; Shackell M; Sutton GC; Fox KM
    Br Heart J; 1985 Jan; 53(1):47-52. PubMed ID: 3881105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral labetalol in the management of stable angina pectoris in normotensive patients.
    Upward JW; Akhras F; Jackson G
    Br Heart J; 1985 Jan; 53(1):53-7. PubMed ID: 3917674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of labetalol on the exercise tolerance test in patients with angina pectoris].
    Cherchi A; Fonzo R; Lai C; Mercuro G
    Boll Soc Ital Cardiol; 1978; 23(1):281-97. PubMed ID: 113022
    [No Abstract]   [Full Text] [Related]  

  • 15. Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
    Frishman WH; Shapiro W; Charlap S
    J Clin Pharmacol; 1989 Jun; 29(6):504-11. PubMed ID: 2666451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of therapy with a association of nifedipine and atenolol in patients with systemic arterial hypertension and angina pectoris].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Nov; 73(44):3191-4. PubMed ID: 7145199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol in the treatment of angina pectoris.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):166-74. PubMed ID: 2881899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Labetalol in the treatment of arterial hypertension. A Brazilian multicenter study].
    Benchimol AB; Sbissa AS; Benchimol CB; Saad EA; Barbosa ET; Albanesi Filho FM; Pillegi F; da Cunha GP; Maranhão MF; Batlouni M; Schlesinger P; Duprat R; Maciel R
    Arq Bras Cardiol; 1982 May; 38(5):421-7. PubMed ID: 6762868
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trial of labetalol in effort angina pectoris].
    Broustet JP; Cherrier JF; Pic A
    Ann Cardiol Angeiol (Paris); 1985 Mar; 34(3):171-6. PubMed ID: 4004091
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.